台灣臨床試驗主持人資料庫|TPIDB

TPIDB > Principal Investigator

Principal Investigator

Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital (在職)

Division of Infectious Disease

更新時間：2023-09-19

李雋元Lee, Chun-Yuan

Co-Principal Investigator

Clinical Trial Experience (year) 7 years 9 個月

Recruiting Trial

21Cases

Profile Clinical Trials List Publication

Highlights

A Phase II, Placebo-controlled, Randomized, Observer-blind Study to Evaluate the Immunogenicity, Safety, and Tolerability of UB-612 Vaccine against COVID-19 in Adolescent, Younger and Elderly Adult Volunteers

The HIV functional cure potential of UB-421: A Phase II, randomized, open-label, controlled, 48-week, proof-of-concept study, to evaluate the safety of UB-421 in combination with standard antiretroviral therapy (ART) and the efficacy of HIV reservoir reduction as compared with ART alone in ART-stabilized HIV-1 patients

Study Area

Human immunodeficiency virus

Professional Experiences

Kaohsiung Municipal Siaogang Hospital

Attending Physician

Infectious disease

2018- 迄今

Education

Kaohsiung Medical University

Graduate Institute of Medicine

Master's degree

2018- 迄今

Clinical Trials List

See All28Cases

2016

Total 28

I 1
I/II 0
II 5
II/III 1
III 20
IV 0
Others 1

Number of Studies by Scale

3件

Taiwan Multiple Center

Taiwan Single Center

0Cases

Taiwan Multiple Center

3Cases

Multi-Regional Multi-Center

25Cases